Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
If you’re being treated for cancer and experiencing symptoms, what would cause you to pick up the phone and call your cancer center? Pain emerged as the number one reason, in a study of 563 patients, who reported 2,378 symptoms during 1,229 phone calls to the James P. Wilmot Cancer Center.
9/10/2013 | 1 comment
William Bonnez, M.D., Richard Reichman, M.D., and Robert C. Rose, Ph.D. are featured in a Spanish book called 40 + 1 Innovators Who Have Changed the World of the 21st Century for their pioneering work on the human papillomavirus (HPV) vaccine.
9/9/2013 | 2 comments
Personalized medicine – or matching a patient’s tumor with an appropriate treatment – is transforming lung cancer and bringing a measure of hope to patients, according to a review by Eric S. Kim, M.D., and Kishan J. Pandya, M.D., of the James P. Wilmot Cancer Center, published in the journal Expert Opinion on Medical Diagnostics.
8/15/2013 | 1 comment
Investigators are widely studying curcumin for possible anti-cancer activity, and now the URMC has discovered that it also helps to reduce peeling, weepy, skin damage during radiation treatment for breast cancer.
8/7/2013 | 0 comments
The decided trend in recent years has been toward a partial kidney resection (removal of tumor only) in cases of small kidney cancers. But contrary to past studies, new URMC data shows that people who received a partial nephrectomy did not have improved survival, according to research published this month in European Urology.
7/25/2013 | 0 comments